JINHAI MEDICAL TECHNOLOGY LIMITED  (the "Company")  (Hong Kong Stock Exchange Stock Code:  2225),  together with its subsidiaries (collectively the "Group"), is a Hong Kong listed company with its headquarter and principal place of business in Shanghai, China. The Group is principally engaged in providing minimally invasive surgery solutions, medical products, and related services in Chinese Mainland.

​

​The Company intends to leverage on its presence in the Chinese Mainland and Hong Kong to expand its current businesses as well as venture into new industries and identify new investment opportunities to enhance its business prospects for the long-term economic benefit of the Company and its shareholders.